Specialty Pharma Journal Specialty, Precision & Technology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–DicernaTM Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of ribonucleic acid …

ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (NASDAQ: EXEL) today announced that two original cohorts are being expanded and …

LOS ANGELES, July 15, 2019 (GLOBE NEWSWIRE) — Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”) today announced the first kidney biopsy result and …

Foster City, Calif. and Mechelen, Belgium — July 14, 2019; 1 pm ET/19.00 CET; regulated information —  Gilead …

RARITAN, N.J., July 12, 2019  — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

LOS ANGELES, July 9, 2019 /PRNewswire/ — ImaginAb Inc., a clinical stage immuno-oncology imaging company, …

WATERTOWN, Mass.–(BUSINESS WIRE)–Lyndra Therapeutics, the company making daily pills a thing of the past, has …

Copenhagen, Denmark; July 8, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that topline …

WALTHAM, Mass., July 8, 2019 /PRNewswire/ — Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it …

RAMSEY, N.J. and BOCA RATON, Fla., July 08, 2019 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. …

WALTHAM, Mass., July 8, 2019 /PRNewswire/ — Skyhawk Therapeutics, Inc. (“Skyhawk”) today announced the expansion …

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL) (Prevail), a …

CASTRES, France–(BUSINESS WIRE)–Pierre Fabre today announced interim analysis results from the Phase 3 BEACON CRC …